Literature DB >> 18594828

Microbubbles improve the ablation efficiency of extracorporeal high intensity focused ultrasound against kidney tissues.

Tinghe Yu1, Dingrong Hu, Chuanshan Xu.   

Abstract

OBJECTIVE: The necrosis rate is low when ablating kidney tissues with extracorporeal high intensity focused ultrasound (HIFU), and this drawback has been limiting the application of ultrasonic therapy. The aim of the present study was to determine whether microbubbles increased the ablation efficiency in vivo.
METHODS: Goat kidneys were exposed to HIFU (control group) or microbubble-assisted HIFU (experimental group). Microbubbles were intravenously injected before focused ultrasound exposure. The linear scan was employed and tissue ablation was performed in manner of a clinical regime. The necrosis rate was determined 24 h after HIFU. Pathological examinations were performed to confirm tissue necrosis and to determine whether there were unaffected tissues within the exposed volume.
RESULTS: The necrosis rate was increased in experimental group (4.17 +/- 1.33 vs. 9.32 +/- 2.27 mm(3)/s, P = 0.0007). Ablated tissues formed a hemorrhagic volume on gross examinations, and the boundary between treated and untreated areas was sharp. There was no intact tissue within the exposed volume. Hemorrhage frequently occurred in insonated parenchymas. Destructed ghost cells just inside the demarcation were full of vacuoles, when introducing microbubbles. In control group, the volumes of ablated tissues varied drastically between animals despite a same treatment template.
CONCLUSION: Microbubbles increased the ablation efficiency of HIFU against kidney tissues. A preoperative regime might poorly predict the therapeutic outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18594828     DOI: 10.1007/s00345-008-0290-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Focused ultrasound ablation of renal and prostate cancer: current technology and future directions.

Authors:  William W Roberts
Journal:  Urol Oncol       Date:  2005 Sep-Oct       Impact factor: 3.498

Review 2.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

3.  Hyperecho as the indicator of tissue necrosis during microbubble-assisted high intensity focused ultrasound: sensitivity, specificity and predictive value.

Authors:  Tinghe Yu; Chuanshan Xu
Journal:  Ultrasound Med Biol       Date:  2008-04-18       Impact factor: 2.998

4.  The use of a micro-bubble agent to enhance rabbit liver destruction using high intensity focused ultrasound.

Authors:  Tinghe Yu; Shuhua Xiong; Timothy J Mason; Zhibiao Wang
Journal:  Ultrason Sonochem       Date:  2005-04-01       Impact factor: 7.491

Review 5.  High-intensity focused ultrasound in the treatment of solid tumours.

Authors:  James E Kennedy
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

6.  Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue.

Authors:  Yukio Kaneko; Toshiyuki Maruyama; Kenji Takegami; Toshiaki Watanabe; Hiroshi Mitsui; Kazuyuki Hanajiri; Hirokazu Nagawa; Yoichiro Matsumoto
Journal:  Eur Radiol       Date:  2005-03-01       Impact factor: 5.315

7.  Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.

Authors:  S Nahum Goldberg; Geoffrey D Girnan; Anatoly N Lukyanov; Muneeb Ahmed; Wayne L Monsky; G Scott Gazelle; Juan Carlos Huertas; Keith E Stuart; Timothy Jacobs; Vladimir P Torchillin; Elkan F Halpern; Jonathan B Kruskal
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

8.  A microbubble agent improves the therapeutic efficiency of high intensity focused ultrasound: a rabbit kidney study.

Authors:  Tinghe Yu; Guoyun Wang; Kai Hu; Ping Ma; Jin Bai; Zhibiao Wang
Journal:  Urol Res       Date:  2003-12-04

Review 9.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

10.  The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population.

Authors:  R O Illing; J E Kennedy; F Wu; G R ter Haar; A S Protheroe; P J Friend; F V Gleeson; D W Cranston; R R Phillips; M R Middleton
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

View more
  6 in total

1.  Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound.

Authors:  Ali Ziadloo; Scott R Burks; Eric M Gold; Bobbi K Lewis; Aneeka Chaudhry; Maria J Merino; Victor Frenkel; Joseph A Frank
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

2.  The influence of distance between microbubbles on the fluid flow produced during ultrasound exposure.

Authors:  Carolyn E Schutt; Stuart D Ibsen; William Thrift; Sadik C Esener
Journal:  J Acoust Soc Am       Date:  2014-12       Impact factor: 1.840

3.  Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery.

Authors:  Jameel A Feshitan; Fotis Vlachos; Shashank R Sirsi; Elisa E Konofagou; Mark A Borden
Journal:  Biomaterials       Date:  2011-10-10       Impact factor: 12.479

4.  Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo.

Authors:  Jonathan A Kopechek; Eunjoo Park; Chang-Sheng Mei; Nathan J McDannold; Tyrone M Porter
Journal:  J Healthc Eng       Date:  2013       Impact factor: 2.682

5.  Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation.

Authors:  Se-Young Choi; Young-Sun Kim; Yeong-Ju Seo; Jehoon Yang; Kyu-Sil Choi
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  High-intensity focused ultrasound in small renal masses.

Authors:  Jose Rubio Briones; Argimiro Collado Serra; Alvaro Gómez-Ferrer Lozano; Juan Casanova Ramón-Borja; Inmaculada Iborra Juan; Eduardo Solsona Narbón
Journal:  Adv Urol       Date:  2008-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.